# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4482795 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of Meis1 gene expression at 1.5 to 6 uM by quantitative RT-PCR analysis | Mus musculus | 1 | assay format | Patent Bioactivity Data | ||
2. | ALA4482807 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of HOX7 gene expression at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
3. | ALA4482808 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of HOX9 gene expression at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
4. | ALA4482809 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of HOX10 gene expression at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
5. | ALA4482810 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of Meis1 gene expression at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
6. | ALA4482815 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of HOX9 gene expression at 1.5 to 6 uM by quantitative RT-PCR analysis | Mus musculus | 1 | assay format | Patent Bioactivity Data | ||
7. | ALA4482816 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of HOX10 gene expression at 1.5 to 6 uM by quantitative RT-PCR analysis | Mus musculus | 1 | assay format | Patent Bioactivity Data |